Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Regulation of lung progenitor plasticity and repair by fatty acid oxidation
Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora
Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora
View: Text | PDF
Research Article Metabolism Pulmonology

Regulation of lung progenitor plasticity and repair by fatty acid oxidation

  • Text
  • PDF
Abstract

Idiopathic pulmonary fibrosis (IPF) is an age-related interstitial lung disease, characterized by inadequate alveolar regeneration and ectopic bronchiolization. While some molecular pathways regulating lung progenitor cells have been described, the role of metabolic pathways in alveolar regeneration is poorly understood. We report that expression of fatty acid oxidation (FAO) genes is significantly diminished in alveolar epithelial cells of IPF lungs by single-cell RNA sequencing and tissue staining. Genetic and pharmacological inhibition in AT2 cells of carnitine palmitoyltransferase 1a (CPT1a), the rate-limiting enzyme of FAO, promoted mitochondrial dysfunction and acquisition of aberrant intermediate states expressing basaloid, and airway secretory cell markers SCGB1A1 and SCGB3A2. Furthermore, mice with deficiency of CPT1a in AT2 cells show enhanced susceptibility to developing lung fibrosis with an accumulation of epithelial cells expressing markers of intermediate cells, airway secretory cells, and senescence. We found that deficiency of CPT1a causes a decrease in SMAD7 protein levels and TGF-β signaling pathway activation. These findings suggest that the mitochondrial FAO metabolic pathway contributes to the regulation of lung progenitor cell repair responses and deficiency of FAO contributes to aberrant lung repair and the development of lung fibrosis.

Authors

Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora

×

Figure 5

Cpt1a deficiency promotes a RAS intermediate phenotype.

Options: View larger image (or click on image) Download as PowerPoint

Cpt1a deficiency promotes a RAS intermediate phenotype.
(A) Upregulated...
(A) Upregulated genes in Cpt1a Spc-KO vs. Cpt1a-floxed mice by epithelial cell type. Red color denotes significantly upregulated genes. (B) UMAP shows the distribution of all cell types and expression of Scgb1a1 in lung epithelial cells from MHV-68–infected Cpt1a Spc-KO (n = 6) and Cpt1a-floxed (n = 4) mice. (C) Heatmap showing z values of the mean expression for canonical epithelial markers and differentially expressed genes in AT1, Intermediate 1, Intermediate 2, and AT1 cell types, alongside basal cell markers. (D) Enrichment pathway analysis of Intermediate 2 cell population in Cpt1a Spc-KO mice. (E) Representative immunofluorescence images of the lungs of MHV-68–infected Cpt1a-floxed (n = 4) and Cpt1a Spc-KO (n = 6) mice. SP-C (white) was used as an AT2 marker, SCGB1 (red) was used as a secretory cell marker, and PDPN (green) was used as an AT1 marker. (F) Top: Scheme of the experiment. Bottom: Immunofluorescent staining and quantification of PCLSs from lineage tracing ROSAmT/mG SPC-Cre-ER mice treated with PBS or etomoxir, depicting higher SCGB1A1 intensity under etomoxir treatment. Data represent mean ± SD, n = 4 per condition. (G) Scheme of the mouse organoid culture experimental design. Representative immunofluorescence images of organoids from Cpt1a-floxed and Cpt1a Spc-KO mice (n = 3, per genotype) showing an increase in Scgb1a1 in Cpt1a Spc-KO mouse organoids. All scale bars: 50 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts